A comparison of 0.2 and 0.4% Ropivacaine for Ambulatory Patient Controlled Interscalene Analgesia after Rotator Cuff Repair.

Trial Profile

A comparison of 0.2 and 0.4% Ropivacaine for Ambulatory Patient Controlled Interscalene Analgesia after Rotator Cuff Repair.

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Ropivacaine (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Nov 2010 Actual initiation date (15 Aug 2008), trial status (recruiting), and lead trial center and investigator (Michael Fredrickson) amended as reported by ClinicalTrials.gov.
    • 29 Nov 2010 New source identified and integrated (Australian New Zealand Clinical Trials Registry).
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top